Bridgebio Pharma Inc (BBIO)

EBITDA Margin

-58.09%

Quarterly · Period ending:

BBIO logo

BBIO EBITDA Margin

Latest reported-58.09%
BBIO Quarterly EBITDA Margin (0.00% → -58.09%)
High-resolution chart · PNG

BBIO ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-58.0935%
-57.8639%
-119.2133%
-143.6164%
-129.068%
-108.1881%
-3,996.0558%
-5,111.8228%
-2,353.9207%
-5.2544%
-8,508.596%
-3,850.9655%
-8,438.2693%
-6,625.3012%
-6,359.3583%
-35,125.1479%
26.1736%
-10,572.7273%
-1,052.4756%
-6,385.8362%
-162.426%
-34,800.4329%
-101,334.4262%
-1,462.9958%
0%
0%
-584.2463%
-217.5573%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.